Eutherian fetoembryonic defense system (eu-FEDS) hypothesis
Hypothetical model of immune tolerance in pregnancy
Eutherian Fetoembryonic Defense System (eu-FEDS) hypothesis is a theoretical model proposed to explain how the immune system of eutherian (placental) mammals recognizes and tolerates a developing embryo and fetus, despite the presence of paternal antigens that would normally elicit an immune response. The model seeks to describe a specialized immune signaling system that allows for recognition of genetically related entities beyond self and non-self, specifically within the context of pregnancy.
In most classical immunological models, the immune system distinguishes between "self" and "non-self" to defend the organism against pathogens. However, during pregnancy, the maternal immune system must tolerate the presence of a semi-allogeneic fetus, which carries both maternal and paternal genetic material. This has posed a long-standing question in reproductive immunology: how is the fetus protected from maternal immune attack?
The eu-FEDS hypothesis suggests that eutherian mammals have evolved a unique immunological recognition system that enables the maternal immune system to identify and tolerate a developing fetus based on "relatedness" or "species-specific" signaling rather than conventional self/non-self discrimination.
Signaling Mechanism
The hypothesis proposes the existence of a distinct signaling mechanism at the maternal-fetal interface. It is theorized that molecules expressed by the fetal trophoblast cells communicate with the maternal immune cells to promote tolerance. These molecules may include:
- Glycoproteins and mucins with unique carbohydrate side chains
- Pregnancy-specific glycoproteins (PSGs)
- Non-classical MHC (Major Histocompatibility Complex) molecules, such as HLA-G
- Tryptophan-degrading enzymes, such as IDO1 (indoleamine 2,3-dioxygenase)
These factors may play roles in modulating maternal immune responses, promoting regulatory T cells, suppressing cytotoxic immune responses, and creating an immunologically privileged site within the placenta.
Evolutionary Context
The eu-FEDS hypothesis is particularly relevant to eutherian mammals, which sustain prolonged intrauterine gestation and rely on the placenta for nutrient and waste exchange. Unlike marsupials or monotremes, eutherians have more intimate and sustained interactions between fetal and maternal tissues, necessitating more complex immune regulation.
The hypothesis implies that the evolution of placental pregnancy required corresponding adaptations in maternal immune recognition systems to prevent rejection of the fetus.
Applications and Implications
The eu-FEDS hypothesis has been invoked to explore potential mechanisms in:
- Pregnancy-related disorders, such as preeclampsia, spontaneous abortion, and recurrent miscarriage
- Cancer, where certain tumors may exploit eu-FEDS-like signaling to avoid immune detection
- Autoimmune disease, where loss of tolerance mechanisms may contribute to disease pathogenesis
- Transplantation tolerance, drawing parallels between fetal tolerance and graft acceptance
Criticism and Limitations
As a theoretical model, eu-FEDS remains hypothetical and has yet to be fully validated through empirical evidence. Critics argue that many of the proposed components of the model are already known in broader immunological contexts and may not constitute a distinct "system." Further research is needed to isolate specific mechanisms and test the predictive power of the hypothesis.
See also
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD